DelveInsight’s Bipolar disorder (BPD) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Bipolar disorder (BPD) for the seven major markets i.e. United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Bipolar disorder (BPD) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Bipolar disorder (BPD) till 2023.
Key Coverage and Benefits
• The report will help in developing business strategies by understanding the trends shaping and driving the global Bipolar disorder (BPD) market.
• Identifying patient populations in the global Bipolar disorder (BPD) market to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Bipolar disorder (BPD) therapeutics in each of the markets covered.
• To understand the future market competition in the global Bipolar disorder (BPD) therapeutics market and Insightful review of the key market drivers and barriers.
Scope
• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2023.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
• It also provides Bipolar disorder (BPD) for United States, EU5 and Japan from 2013 and forecasted Market to 2023
Note: This report requires 7-10 business days to complete.
.
'
Table of Contents
• Bipolar disorder (BPD) overview
• Pathophysiology
• Symptoms of disease
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Bipolar disorder (BPD) Market
• Global Epidemiology of Bipolar disorder (BPD) Forecasted to 2023
• Global Market (2013-2015)
• Global Forecasted Market (2016-2023)
• Global Market by Geography
• Market of US (2013-2015)
• Forecasted Market of US (2016-2023)
• Market of Europe
• Market of Germany (2013-2015)
• Forecasted Market of Germany (2016-2023)
• Market of United Kingdom (2013-2015)
• Forecasted Market of United Kingdom (2016-2023)
• Market of France (2013-2015)
• Forecasted Market of France (2016-2023)
• Market of Italy (2013-2015)
• Forecasted Market of Italy (2016-2023)
• Market of Spain (2013-2015)
• Forecasted Market of Spain (2016-2023)
• Market of Japan (2013-2015)
• Forecasted Market of Japan (2016-2023)
• Market of ROW (2013-2015)
• Forecasted Market of ROW (2016-2023)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Bipolar disorder (BPD) Drug Sales (USD Millions)
• Table 6: Global Epidemiology of Bipolar disorder (BPD) (2013-2023)
• Table 7: Bipolar disorder (BPD) Global Market (USD Millions), (2013-2015)
• Table 8: Bipolar disorder (BPD) Global Market (USD Millions), (2016-2023)
• Table 9: Bipolar disorder (BPD) US Market (USD Millions), (2013-2015)
• Table 10: Bipolar disorder (BPD) US Market (USD Millions), (2016-2023)
• Table 11: Bipolar disorder (BPD) Germany Market (USD Millions), (2013-2015)
• Table 12: Bipolar disorder (BPD) Germany Market (USD Millions), (2016-2023)
• Table 13: Bipolar disorder (BPD) United Kingdom Market (USD Millions), (2013-2015)
• Table 14: Bipolar disorder (BPD) United Kingdom Market (USD Millions), (2016-2023)
• Table 15: Bipolar disorder (BPD) France Market (USD Millions), (2013-2015)
• Table 16: Bipolar disorder (BPD) France Market (USD Millions), (2016-2023)
• Table 17: Bipolar disorder (BPD) Italy Market (USD Millions), (2013-2015)
• Table 18: Bipolar disorder (BPD) Italy Market (USD Millions), (2016-2023)
• Table 19: Bipolar disorder (BPD) Spain Market (USD Millions), (2013-2015)
• Table 20: Bipolar disorder (BPD) Spain Market (USD Millions), (2016-2023)
• Table 21: Bipolar disorder (BPD) Japan Market (USD Millions), (2013-2015)
• Table 22: Bipolar disorder (BPD) Japan Market (USD Millions), (2016-2023)
• Table 23: Bipolar disorder (BPD) ROW Market (USD Millions), (2013-2015)
• Table 24: Bipolar disorder (BPD) ROW Market (USD Millions), (2016-2023)
List of Figures
• Figure 1: Bipolar disorder (BPD) Drug Sales (USD Millions)
• Figure 2: Global Epidemiology of Bipolar disorder (BPD) (2013-2023)
• Figure 3: Bipolar disorder (BPD) Global Market (USD Millions), (2013-2015)
• Figure 4: Bipolar disorder (BPD) Global Market (USD Millions), (2016-2023)
• Figure 5: Bipolar disorder (BPD) US Market (USD Millions), (2013-2015)
• Figure 6: Bipolar disorder (BPD) US Market (USD Millions), (2016-2023)
• Figure 7: Bipolar disorder (BPD) Germany Market (USD Millions), (2013-2015)
• Figure 8: Bipolar disorder (BPD) Germany Market (USD Millions), (2016-2023)
• Figure 9: Bipolar disorder (BPD) United Kingdom Market (USD Millions), (2013-2015)
• Figure 10: Bipolar disorder (BPD) United Kingdom Market (USD Millions), (2016-2023)
• Figure 11: Bipolar disorder (BPD) France Market (USD Millions), (2013-2015)
• Figure 12: Bipolar disorder (BPD) France Market (USD Millions), (2016-2023)
• Figure 13: Bipolar disorder (BPD) Italy Market (USD Millions), (2013-2015)
• Figure 14: Bipolar disorder (BPD) Italy Market (USD Millions), (2016-2023)
• Figure 15: Bipolar disorder (BPD) Spain Market (USD Millions), (2013-2015)
• Figure 16: Bipolar disorder (BPD) Spain Market (USD Millions), (2016-2023)
• Figure 17: Bipolar disorder (BPD) Japan Market (USD Millions), (2013-2015)
• Figure 18: Bipolar disorder (BPD) Japan Market (USD Millions), (2015-2023)
• Figure 19: Bipolar disorder (BPD) ROW Market (USD Millions), (2013-2015)
• Figure 20: Bipolar disorder (BPD) ROW Market (USD Millions), (2016-2023)
• Otsuka
• AstraZeneca
• Eli Lilly
• Allergan
• Dainippon Sumitomo
• Janssen
• Lundbeck
• Meiji Seika
